Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03816644 · ClinicalTrials.gov registry record · NA
5-Cog Battery for Detecting Cognitive Impairment and Dementia
A NA study, sponsored by Albert Einstein College of Medicine.
- Completed
- Registry status
- NA
- Development phase
- 1,201
- Enrollment target
NCT03816644: Completed NA study, sponsored by Albert Einstein College of Medicine.
NCT03816644 is a NA study that has completed, run by Albert Einstein College of Medicine. The registered enrollment target is 1,201 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (14% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03816644, a NA study, has completed, sponsored by Albert Einstein College of Medicine.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,201 participants
- Enrollment target
Study Summary
Despite the availability of numerous cognitive assessment tools, cognitive impairment related to dementia is frequently under-diagnosed in primary care settings. The investigators have developed a 5-minute cognitive screen (5-Cog) coupled with a decision tree to overcome the technical, cultural and logistic barriers of current cognitive screens to improve dementia care in primary care patients with cognitive concerns.
Primary Outcome
Dementia care is defined as the occurrence of any of the following endpoints following the screening visit. The endpoint is the number of participants who received 1 or more of the following orders: 1. Any new diagnosis of dementia (relevant International Classification of Diseases (ICD)-10 codes) or Mild Cognitive Impairment (MCI) documented in the EMR. 2. Tests ordered for reversible causes of cognitive impairment as recommended by the published guidelines of professional societies (i.e. thyr
Interventions
- OTHER 5-Cog
- OTHER Health Literacy & Grip Assessment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,201 participants |
| Start Date | 2019-05-28 |
| Est. Completion | 2023-03-15 |
| Phase | NA |
What the finished NCT03816644 record still lists
NCT03816644 is an interventional study that assigns participants to a tested intervention. Its 1,201 participants enrollment target places it among the larger protocols in the corpus, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (14% lower).
The record links to 0 conditions, and to 2 interventions - of which 5-Cog is the first listed.
NCT03816644 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03816644 about?
NCT03816644 is a clinical study titled "5-Cog Battery for Detecting Cognitive Impairment and Dementia". Despite the availability of numerous cognitive assessment tools, cognitive impairment related to dementia is frequently under-diagnosed in primary care settings. The investigators have developed a 5-minute cognitive screen (5-Cog) coupled with a decision tree to overcome the technical, cultural and ...
What is the current status of trial NCT03816644?
This trial is currently completed. It is a NA study. The enrollment target is 1,201 participants. The study started on 2019-05-28. Estimated completion is 2023-03-15.
What interventions are being tested in trial NCT03816644?
The interventions under investigation include: 5-Cog (OTHER), Health Literacy & Grip Assessment (OTHER).
Who is sponsoring clinical trial NCT03816644?
This trial is sponsored by Albert Einstein College of Medicine, which has 175 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03816644's enrollment target sits among peer trials
1,201 83rd of 2000 higher than 1,918 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001987 · 1,200 participants
Genetic Studies of Insulin and Diabetes
- NCT00477100 · 1,200 participants
Biospecimen and Medical Data Collection and Tumor Biopsy in Creating Research Tissue Registry in Patients With Inflammatory or Invasive Breast Cancer
- NCT01209000 · 1,200 participants
Nephrotic Syndrome Study Network
- NCT01944332 · 1,200 participants · NA
Gamete Treatment to Correct Fertilization Failure
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI